ATOSSA GENETICS INC 4
4 · ATOSSA GENETICS INC · Filed Jan 21, 2016
Insider Transaction Report
Form 4
Chen Shu-Chih
DirectorChief Scientific Officer10% Owner
Transactions
- Purchase
Common Stock
2016-01-19$0.20/sh+50,000$10,000→ 4,318,315 total(indirect: See Footnote)
Footnotes (2)
- [F1]Represents 50,000 shares purchased in an at-market transaction directly from Atossa Genetics, Inc.
- [F2]Consists of 4,318,315 shares of common stock owned by Ensisheim Partners, LLC ("Ensisheim"). Shu-Chih Chen, Ph.D. and Steven C. Quay, M.D., Ph.D., share voting and investment power over the securities held by Ensisheim. Ensisheim is solely owned and controlled by Drs. Chen and Quay, and, as a result, Drs. Chen and Quay are deemed to be beneficial owners of the shares held by this entity.